Form 4: Twist Bioscience President and COO Sells Shares to Cover Tax Obligations

Twist Bioscience's President and COO, Patrick John Finn, sold shares to cover tax withholding obligations related to vested Restricted Stock Units.

Summary

• Twist Bioscience Corp's President and COO, Patrick John Finn, sold 1,839 shares of common stock on February 21, 2025.
• The sale was executed at a price of $44.177 per share.
• The transaction was made to cover tax withholding obligations from the vesting of Restricted Stock Units.
• This was a mandated 'sell to cover' transaction under the company's equity incentive plan, not a discretionary trade.
• Following the transaction, Finn owns 267,724 shares, including those acquired under the Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is neutral, reporting a standard transaction without any positive or negative implications.

Positives

• The transaction was a mandated 'sell to cover' for tax purposes, indicating compliance with company policy.
• Finn retains a significant holding of 267,724 shares, demonstrating continued investment in the company.
• The filing includes shares acquired under the Employee Stock Purchase Plan, which can be seen as a positive sign of employee participation.

Negatives

• The sale reduces Finn's direct ownership in the company, although it was for tax purposes.

Risks

• There are no specific risks outlined in this document, as it is a standard Form 4 filing.

Future Outlook

The document does not contain any explicit forward-looking statements.

Management Comments

• The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

This is a standard SEC filing related to insider transactions and doesn't provide broader industry context.

Comparison to Industry Standards

• This Form 4 filing is a standard regulatory requirement for reporting changes in beneficial ownership by company insiders.
• The 'sell to cover' mechanism is a common practice among companies with equity compensation plans to handle tax obligations for employees.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders, as it is a routine sale to cover tax obligations.

Key Dates